- Trinity Biotech (TRIB) will change its ADS ratio from 1 ADS representing 20 Class A ordinary shares to 1 ADS representing 600 Class A ordinary shares.
- The ratio change has the same effect as a 1-for-30 reverse ADS split for existing ADS holders.
- The reverse ADS split is expected to become effective at the open of trading on July 24, 2026.
- The move is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- TRIB shares down 17.8% premarket.
Trinity Biotech announces 1-for-30 ADS reverse split; shares down
Trinity Biotech (TRIB) will change its ADS ratio from 1 ADS representing 20 Class A ordinary shares to 1 ADS representing 600 Class A ordinary shares. The ratio change has the same effect as a 1-for-30 reverse ADS split for existing ADS holders. The reverse ADS split is expected to become effective at the open of trading on July 24, 2026. The move ...